Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb

Brain and Development

Volumn 35, Issue 3, 2013, Pages 252-260

  Shu, Hai Feng ^a   Yu, Si Xun ^a   Zhang, Chun Qing ^a   Liu, Shi Yong ^a   Wu, Ke Fu ^a   Zang, Zhen Le ^a   Yang, Hui ^a   Zhou, Shi Wen ^a   Yin, Qing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Epilepsy; Focal cortical dysplasia; Malformations of cortical development; Transient receptor potential vanilloid receptor 1; Tuberous sclerosis complex

Indexed keywords

CASPASE 3; CYTOPLASM PROTEIN; VANILLOID RECEPTOR 1;

ARTICLE; BRAIN CORTEX LESION; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; CYTOPLASM; EPILEPSY; FEMALE; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD; SUBSTANTIA NIGRA; TUBEROUS SCLEROSIS; WESTERN BLOTTING;

ADOLESCENT; BLOTTING, WESTERN; CASPASE 3; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; TRPV CATION CHANNELS; TUBEROUS SCLEROSIS;

EID: 84873747457     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2012.04.007     Document Type: Article

References (28)

1. Palmini A., Najm I., Avanzini G., Babb T., Guerrini R., Foldvary-Schaefer N., et al. Terminology and classification of the cortical dysplasias. Neurology 2004, 62:S2-S8.
2. Crino P.B., Nathanson K.L., Henske E.P. The tuberous sclerosis complex. New Engl J Med 2006, 355:1345-1356.
3. Cepeda C., Andre V.M., Yamazaki I., Hauptman J.S., Chen J.Y., Vinters H.V., et al. Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II. Epilepsia 2010, 51(Suppl. 3):160-165.
4. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature 2001, 413:203-210.
5. Kauer J.A., Gibson H.E. Hot flash: TRPV channels in the brain. Trends Neurosci 2009, 32:215-224.
6. Fu M., Xie Z., Zuo H. TRPV1: a potential target for antiepileptogenesis. Med Hypotheses 2009, 73:100-102.
7. Gibson H.E., Edwards J.G., Page R.S., Van Hook M.J., Kauer J.A. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 2008, 57:746-759.
8. Clement A.B., Hawkins E.G., Lichtman A.H., Cravatt B.F. Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J Neurosci 2003, 23:3916-3923.
9. Steffens M., Schulze-Bonhage A., Surges R., Feuerstein T.J. Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids. Neurosci Lett 2005, 385:13-17.
10. Bhaskaran M.D., Smith B.N. Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy. Exp Neurol 2010, 223:529-536.
11. Blumcke I., Thom M., Aronica E., Armstrong D.D., Vinters H.V., Palmini A., et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2010, 52:158-174.
12. Shu H.F., Zhang C.Q., Yin Q., An N., Liu S.Y., Yang H. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. J Neuropath Exp Neurol 2010, 69:838-849.
13. Schick V., Majores M., Engels G., Hartmann W., Elger C.E., Schramm J., et al. Differential Pi3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells. Brain Pathol 2007, 17:165-173.
14. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A 2000, 97:3655-3660.
15. Chamberlain W.A., Prayson R.A. Focal cortical dysplasia type II (malformations of cortical development) aberrantly expresses apoptotic proteins. Appl Immunohisto Mol Morphol 2008, 16:471-476.
16. Maldonado M., Baybis M., Newman D., Kolson D.L., Chen W., McKhann G., et al. Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol Dis 2003, 14:279-290.
17. D'Amelio M., Cavallucci V., Cecconi F. Neuronal caspase-3 signaling: not only cell death. Cell Death Differ 2010, 17:1104-1114.
18. Peters J.H., McDougall S.J., Fawley J.A., Smith S.M., Andresen M.C. Primary afferent activation of thermosensitive TRPV1 triggers asynchronous glutamate release at central neurons. Neuron 2010, 65:657-669.
19. Karlsson U., Sundgren-Andersson A.K., Johansson S., Krupp J.J. Capsaicin augments synaptic transmission in the rat medial preoptic nucleus. Brain Res 2005, 1043:1-11.
20. Al-Hayani A., Wease K.N., Ross R.A., Pertwee R.G., Davies S.N. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 2001, 41:1000-1005.
21. Cepeda C., Andre V.M., Vinters H.V., Levine M.S., Mathern G.W. Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia?. Epilepsia 2005, 46(Suppl. 5):82-88.
22. Cepeda C., Hurst R.S., Flores-Hernandez J., Hernandez-Echeagaray E., Klapstein G.J., Boylan M.K., et al. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 2003, 72:472-486.
23. Cepeda C., Andre V.M., Levine M.S., Salamon N., Miyata H., Vinters H.V., et al. Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis. Epilepsy Behav 2006, 9:219-235.
24. Liu R.S., Lemieux L., Bell G.S., Hammers A., Sisodiya S.M., Bartlett P.A., et al. Progressive neocortical damage in epilepsy. Ann Neurol 2003, 53:312-324.
25. Velagapudi C., Bhandari B.S., Abboud-Werner S., Simone S., Abboud H.E., Habib S.L. The tuberin/mTOR pathway promotes apoptosis of tubular epithelial cells in diabetes. J Am Soc Nephrol 2011, 22:262-273.
26. Reith R.M., Way S., McKenna J., Haines K., Gambello M.J. Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration. Neurobiol Dis 2011, 43:113-122.
27. Shirakawa H., Yamaoka T., Sanpei K., Sasaoka H., Nakagawa T., Kaneko S. TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons. Biochem Bioph Res Commun 2008, 377:1211-1215.
28. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 2008, 49:8-21.